EQ
Price
$1.15
Change
+$0.09 (+8.49%)
Updated
Jan 16 closing price
Capitalization
70.03M
67 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$7.55
Change
-$0.06 (-0.79%)
Updated
Jan 16 closing price
Capitalization
431.37M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EQ vs FDMT

Header iconEQ vs FDMT Comparison
Open Charts EQ vs FDMTBanner chart's image
Equillium
Price$1.15
Change+$0.09 (+8.49%)
Volume$531.61K
Capitalization70.03M
4D Molecular Therapeutics
Price$7.55
Change-$0.06 (-0.79%)
Volume$754.69K
Capitalization431.37M
EQ vs FDMT Comparison Chart in %
EQ
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EQ vs. FDMT commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Hold and FDMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (EQ: $1.15 vs. FDMT: $7.55)
Brand notoriety: EQ and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 73% vs. FDMT: 78%
Market capitalization -- EQ: $70.03M vs. FDMT: $431.37M
EQ [@Biotechnology] is valued at $70.03M. FDMT’s [@Biotechnology] market capitalization is $431.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, EQ is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 5 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • EQ’s TA Score: 5 bullish, 5 bearish.
  • FDMT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, EQ is a better buy in the short-term than FDMT.

Price Growth

EQ (@Biotechnology) experienced а +0.88% price change this week, while FDMT (@Biotechnology) price change was +0.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

EQ is expected to report earnings on Mar 26, 2026.

FDMT is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($431M) has a higher market cap than EQ($70M). FDMT YTD gains are higher at: 0.667 vs. EQ (-25.806). EQ has higher annual earnings (EBITDA): -23.68M vs. FDMT (-222.95M). FDMT has more cash in the bank: 305M vs. EQ (33.1M). EQ has less debt than FDMT: EQ (745K) vs FDMT (22.3M). EQ has higher revenues than FDMT: EQ (4.39M) vs FDMT (120K).
EQFDMTEQ / FDMT
Capitalization70M431M16%
EBITDA-23.68M-222.95M11%
Gain YTD-25.8060.667-3,871%
P/E RatioN/AN/A-
Revenue4.39M120K3,660%
Total Cash33.1M305M11%
Total Debt745K22.3M3%
FUNDAMENTALS RATINGS
EQ: Fundamental Ratings
EQ
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EQFDMT
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EQ
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PYNKF0.260.01
+3.42%
Perimeter Medical Imaging AI, Inc.
OBIIF32.17N/A
N/A
Obic Co. Ltd.
TYOYY90.22N/A
N/A
Taiyo Yuden Co. Ltd.
NFPC17.02N/A
N/A
Northfield Precision Instrument Corp.
SEEMF0.07-0.01
-8.61%
Seeing Machines Ltd.

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with NEVPF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
+8.49%
NEVPF - EQ
33%
Loosely correlated
N/A
IMNM - EQ
33%
Poorly correlated
-1.93%
FDMT - EQ
33%
Poorly correlated
-0.79%
ACXP - EQ
26%
Poorly correlated
-1.49%
MURA - EQ
24%
Poorly correlated
N/A
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-0.79%
RGNX - FDMT
46%
Loosely correlated
-1.02%
CLDX - FDMT
46%
Loosely correlated
-0.16%
RCUS - FDMT
44%
Loosely correlated
+0.05%
VIR - FDMT
44%
Loosely correlated
-2.26%
TNGX - FDMT
44%
Loosely correlated
+11.29%
More